Dr. A. Reza Kamarei
Founder & CEO

Dr. A. Reza Kamarei is a seasoned global executive, entrepreneur, consultant, and advisor with over 40 years of success across the food, nutrition, health & wellness, and management consulting industries. He is the Founder and CEO of Ideas Trading Center and President of Kamarei Consulting.

A creative and results-driven leader, Dr. Kamarei has deep R&D and management expertise in functional foods and beverages, dietary supplements, nutritional and medical foods, health & wellness products, nutraceuticals, and cosmeceuticals. He fosters strong cross-functional collaborations to strategically bring innovative products to market. His proven ability in business development has consistently driven growth and profitability for global corporations, national firms, and entrepreneurial ventures.

EDUCATION

• Key contributor to the NASA-sponsored project: “Feasibility of Producing a Range of Food Products from a Limited Range of Undifferentiated Major Food Components for Future Manned Space Habitats.” NASA Citation

• Recipient of the prestigious Dr. Hedayat’s Prize, named after the father of modern nutrition science in Iran, as the first expatriate Iranian food and nutrition scientist to receive the honor.

• Author of the science book Puzzle of Fate: Is Your Fate Predetermined or Can You Change It?

PROFESSIONAL EXPERIENCE

• Established the world’s first patent-pending Ideas Trading Platform to facilitate confidential transactions between idea generators and buyers.

• Assembled an elite International Board of Patent Advisors and Scientific Advisors.

• Aggregated a portfolio of innovative nutritional technologies and formulations for licensing opportunities.

• Built the scientific foundation of the company.

• Developed innovative juice-based probiotic dietary supplements and medical foods.

• Led in-vitro experiments and clinical trials.

• Demonstrated superior survivability of juice-based probiotics in stomach acid.

• Authored peer-reviewed papers and filed multiple patent applications.

• Successfully led the global team of R&D - Nutrition and Health. Developed SWOT analysis, mission of Business Unit, and determined and implemented R&D strategy.

• Proposed innovative ideas for using various plants for different health benefits/claims (e.g., a new Ginger powder with moderate amount of gingerols and shogaols for better clinical efficacy, a new Garlic powder considering alliin and allicin contents or commercial garlic products, a new natural emulsifier for dissolution and better bioavailability of curcumin).

• Managed proper implementation of a range of R&D projects in Stage-Gate innovation pipeline (e.g., determined top 10 plant sources for all essential vitamins and minerals.  Proved the concept for isolation of natural Vitamin B9 (folic acid) from beans.

• Partnered with TRU-ID for DNA authenticity analysis of ingredients and natural health products.

• Scientifically reviewed acquired technologies (e.g., mushroom protein, dried ginger extract).

• Managed detection of adulteration of Ashwagandha roots by aerial parts (TLC & HPLC), natural Curcumin with synthetic Curcumin (C14 analysis) and WADA substances in Rhodiola (GC).

• Led resolution of hundreds of Customers’ Technical Requests to customer satisfaction.

• Created a high morale R&D environment and trained R&D staff.

• Formulated and developed the Sanutra Wellness line of 11 dietary supplements (Joint Health, Cardio & Cholesterol, Blood Sugar Health, Weight Management, Bone Health, Immunity Health, Memory Health, Colon Health, Skin, Hair & Nails Health, Healthy-Aging and Relax & Sleep).

• Provided a variety of scientific/technological help (including visits and presentations to customers) to the members of Sales & Marketing team towards closing sales deals.

• Wrote articles and answered interview questions for trade magazines (e.g., Nutritional Outlook, Nutraceuticals World and Functional Ingredients).

• Generated, reviewed, and commented on business and scientific documents.

• Attended company-sponsored trade shows and provided support to members of the marketing/sales teams in dealing with customers.

• Generated novel, patentable ideas and reduced them to practice.

• Reviewed and commented on protocols of clinical trials, and technologies presented for licensing.

• Developed a technology that was the basis of Coca-Cola 2008 top prize for innovative products.

• Developed prototypes of invented ideas such as neutralized fruit juice with milk and soymilk, nutritional beverages containing polyphenols, nutritional beverage for bone health, micronutrients-simulated orange juice, juice coffee, wake-up juice, and juice cola/root beer.

• Developed a comprehensive white paper on the health benefits of orange juice phytonutrients including state of science and potential business opportunities.

• Analyzed 550 patents on polyphenolics and capabilities of ingredient and product companies, and R&D institutions/investigators.  Suggested potential research areas for future investments.

• Negotiated with Bioenergy, Inc. arranging a clinical trial on the effects of oral D-ribose.

• Developed and presented a detailed proposal on Nutrigenomics of orange juice phytonutrients.

• Prepared a detailed plan for establishment of the Technical Patent Committee.

• Re-organized structure and functions of Nutrition Department (annual budget $1.7 million, 15 scientific staff) according to the strategic concept of vertical integration (from raw materials to processed aquacultured shrimp and fish). 

• Developed glucosamine from shell of “aquacultured” shrimp, and fish oil from byproducts of aquacultured fish. Presented results at the World Aquaculture Society (WAS).

• Published the Food Technology Feature Paper “Designing Clinical Trials to Substantiate Claims” which has been used as a reference document in many food and nutrition companies.

• Established the company, developed strategy and business plan, developed and consumer tested four lines of fresh, refrigerated, ultra-pasteurized or pasteurized nutritionally complete products (Heavenly Nutritionä, Slim-Freshä, Nutra-Freshä, and Infant-Freshä).  These products were targeted for the milk products market, nutritional supplements market, and liquid infant formula market. 

• Obtained five comprehensive US patents on freshly-prepared nutritional supplements, milk and milk products, and infant formulas.

• Established the R&D department of Nutritional & Medical Food Ingredients. 

• Developed global mission, strategy, and short-term and long-term specific goals.

• Proposed the composition of nutritional starches for diabetes and colon cancer.  Planned and initiated multinational clinical and pre-clinical studies to determine the physiological effects of nutritional starches on diabetes and colon cancer.

• Proposed to the FDA (as a response to Advance Notice of Proposed Rulemaking) guidelines for the regulation of Medical Foods and Medical Food companies.

• Identified viable business opportunities for future medical foods through analyses of the top Medical Food competitors’ lines of business, financial profiles, and global patents and products.

• Formulated and developed Clintec’s first pediatric whole protein liquid diet (UHT-treated for oral consumption and retort-treated for spike and hang application).  Developed texture-modified food prototypes, with high sensory scores for dysphagic patients.

• Managed scientific and administrative functions of R&D.  Controlled a $13.3 million budget.  Led cross-functional teams and a portfolio of more than 40 R&D projects.  Kept R&D costs 9% under budget.

• Coordinated efforts of R&D including clinical trials with sales, marketing, regulatory, manufacturing, and external contractors.  Brought more than 40 SKUs of enteral & parenteral products to market.

• Initiated and significantly contributed to numerous R&D and marketing programs such as Time-To-Market, R&D policies and procedures and Parenteral TQM.  Expanded team management systems and performance awards.

• Managed development of oral Peptamenâ, Clintec’s most successful enteral product, as well as NutriHepâ, the world’s first RTD amino acid-based oral product.

• Originated and implemented a practical marketing and sales strategy which significantly contributed to the company’s successful Initial Public Offering (IPO), raising more than $10 million in capital.

• Established and directed Bioprocessing Operations for a pilot plant and large-scale production of more than 10 codes of bioactive and cosmetic products and by-products.

• Led a team of five professionals in developing techniques for the isolation and quality control of fine biochemicals from porcine and bovine tissues.

ISSUED AND PENDING PATENTS

• US Patent Application 63/705,394 “Juice-based Probiotic Blend for Resistance to Stomach Acid”, A. R. Kamarei, Howards and E. Finkelstein.

• International Application, A. R. Kamarei “Ideas Trading Platform” PCT/US24/19440

• International Application R. F. Howards, A. R. Kamarei, R. Finkelstein, L. Robins and E. Finkelstein “Probiotic Formulations and Methods of Use Thereof”.

• US Patent Application R.F. Howards, A. R. Kamarei, E. Finkelstein “Women’s Health Probiotic Formulation and Methods of Use thereof”

• International Application WO/2021/081362 R.F. Howards, A. R. Kamarei, Michael W. Koschitz “Synbiotic Compositions for Gut Microbiota”

• US Patent Application 16/544,239 A.R. Kamarei “Nutritionally Premium Cola Carbonated Soft Drink - Composition, Method of Preparation and Applications”

• US Patent Application 16/377/668 A.R. Kamarei “Method of Enhancing Bioavailability of Insoluble Bioactive Compounds Using Soluble Natural Gums and Compositions Thereof”

• US Patent Application 20140303258 M. Majeed, A.R. Kamarei, B. Bhat, N. Sankaran "Method of solubilizing insoluble bioactive compounds using triterpene glycosides and compositions thereof"

• US Patent Application 20100178390 A. R. Kamarei, K. Drozdowski “Micronutrient-Simulated Beverages”

• US Patent Application 20100159100 O. Buysschaert, A. Van Ooij, T. Anglea, A.R. Kamarei “Flavonoid-Rich Citrus Extract and Composition Thereof”

• US Patent Application 20090104312 A. R. Kamarei, T. Anglea, Y. Kang “Neutralized Juice-Based Beverages and Method of Making Same”

• US Patent Application 20080118603 M. Lada, A.R. Kamarei, T. Anglea “Nutritional Beverage for Optimal Bone Health”

• US Patent 6,194,009 (February 27, 2001); A.R. Kamarei; "Refrigeration-Shelf-Stable Ultra-pasteurized or Pasteurized Infant Formula"

• US Patent 6,093,425 (July 25, 2000); A.R. Kamarei; "Complete Nutritional Milk Compositions and Products"

• US Patent 6,039,985 (March 21, 2000); A.R. Kamarei; "Refrigeration-Shelf-Stable Ultra-pasteurized or Pasteurized Infant Formula"

• US Patent 6,030,650 (February 29, 2000); A.R. Kamarei; "Complete Nutritional Milk Compositions and Products"

• US Patent 5,985,339 (November 16, 1999); A.R. Kamarei; "Refrigeration-Shelf-Stable Ready-To-Drink Complete Nutritional Compositions and Products"

• US Patent 5,571,783 (November 5, 1996); D. Montagne, A.R. Kamarei, G. Vaussard; E. Leopold, S. Trimbo; "Composition and Method for Treating Patients with Hepatic Disease."

• US Patent 5,470,839 (November 28,1995); P. Laughlin, J. Alexander, A.R. Kamarei, R.P. Dobbie, P. Lin, S-Y Chang, S. Reddy, E. Grasset, C. Melin; "Enteral Diet and Method for Providing Nutrition to a Diabetic."

• US Patent 5,066,496 (November 19, 1991); S. Szabo, M.S.A. Rubin, M. Klibaner, A.R. Kamarei, R.S. Sinn, N. Catsimpoolas; "Composition and Method for Treatment of Gastric and Duodenal Ulcers and Mucosal Erosions."

• US Patent 4,957,741 (September 18, 1990); A.R. Kamarei, N. Catsimpoolas, R. McCluer, T. Mise, R.S. Sinn; "Method for the Treatment of Gastric Ulcer."

• WO Patent 90/09185 (August 23, 1990); S. Szabo, M.S.A. Rubin, M. Klibaner, A.R. Kamarei; "Composition and Method for Treatment of Gastric and Duodenal Ulcers and Mucosal Erosions."

• US Patent 4,879,312 (November 7, 1989); A.R. Kamarei, M. Klibaner, D. Peton; "Method for Enhancing or Provoking Angiogenesis Using Angiogenically Active Omega-3 Polyunsaturated Fatty Acids."

• US Patent 4,879,114 (November 7, 1989); South Africa (86/9568), N. Catsimpoolas, A.R. Kamarei, A.L. Griffith, R-S. Sinn; "Lipid from Omentum and Method for Cosmetic Use."

• EP Patent 0,338,459 A2 (October 10, 1989); H. Solomon, N. Catsimpoolas, J. Mirsky, A.R. Kamarei, J.D. Klein, M.A. Bishop, R.S. Sim; "Composition for Promoting Hair Growth in Androgenetic Alopecia and Method Thereof. "

• US Patent 4,776,173 (October 11, 1988); Australia (AU-B 68392/87); South Africa (86/9469) A.R. Kamarei, R.S. Sinn; "Method for Extracting a Substance from Animal Derived Material."

• WO Patent 88/04931 (July 14, 1988); H. Solomon, N. Catsimpoolas, J.D. Klein, A.R. Kamarei; "Method and Composition for Hair Growth in Common Pattern Baldness."

• US Patent 4,749,522 (June 7, 1988); New Zealand (218 111); Spain (860 2850-2); South Africa (86/832 1) A.R- Kamarei; "Supercritical Fluid Extraction of Animal Derived Material."

PUBLISHED ARTICLES

• Kamarei, A.R., Robins H.F. and Finkelstein E. (2024) Juice-Based Living Probiotics Survive Stomach Acid Significantly better than Dry Powder Live Probiotics. J Biochem Physiol 7:4.

• Kamarei, A.R., Robins H.F. and Finkelstein E. (2024) Inhibition of Epsilon Toxin-Producing Clostridium perfringens with a Juice-Based Probiotic Medical Food for Dietary Management of Multiple Sclerosis. Int J Prev Med Care, 2(1), 01-12.

• Robins H.F., Kamarei, A.R. and Finkelstein E. (2024) Inhibition of E. coli and C. albicans with a Dietary Women’s Health Formulation. Journal of Food Science and Nutrition Research, 7(2024): 64-73.

• Kamarei, A.R. (2021) Vitamin C is the Best Substitute for Phosphoric Acid in Cola Drinks, International Journal of Food Science and Nutrition, 6(4):84-90

• Kamarei, A.R. (2021) Health Risks of Phosphoric Acid in Cola Drinks, International Journal of Food Science and Nutrition, 6(4):13-17

• Robins HF and Kamarei, AR (2021) Beneficial Effect of a Juice-Based Probiotic for Colon Health, J Gastroenterol Res 5(1):190-196

• Robins HF and Kamarei, AR (2020) Complete Inhibition of Clostridium difficile with a Probiotic Juice Beverage, J Gastroenterol Res 4(1):104-111

• Kamarei A. R. (2019) Coconut water nutrition and manufacturing, Natural Products INSIDER, Feb. 2019

• Kamarei, A. R. (2012) Advances in Tablet Formulation for Dietary Supplements, INSIDER, July 2012, 52

• Majeed, M. and Kamarei, A.R. (2012) Bacillus coagulans: Probiotic of Choice, NutraCos, March/April 2012, 19-21

• Kamarei, A. R. (2011) Energy Ingredients that Create Winning Products, Functional Ingredients, March 2011, 42-51

• Kamarei, A. R., Trygstad, C.; 2004 Designing Clinical Trials to Substantiate Claims, Food Technology, 58 (10): 28-35.

• Obaldo, L. G., Kamarei, A.R., and Huang, A.S.; 2004 Sensory Qualities of Aquacultured Amberjack Global Aquaculture Advocate 7(1) 21-22.

• Obaldo, L. G. and Kamarei, A.R; 2003 U.S Farm Metrics Help Establish Process Engineering for Value-Added Shrimp Products. Global Aquaculture Advocate 6(6) 20-21 and 27.

• Klibaner, M., Wallstrom, A.C., Akselband, Y., and Kamarei, A.R.; 1990 Ganglioside GM1 Enhances Migration and Proliferation of Microvascular Endothelial Cells.  Digestive Diseases and Sciences 35(8) 1034, A-10.

• McCluer, R.H., Evans, J.E., Kamarei, A.R., and Williams, M.; 1989 Characterization of Porcine Omental Lipids.  Lipids 24(11) 951-956.

• Klibaner, M., Kamarei, A.R., Wallstrom, A.C., and Peton, D.; 1989 Omega-3 Fatty Acids are Angiogenic.  American Society for Cell Biology.  Abstract-November.

• Kamarei, A.R., Nakhost, Z., and Karel, M.; 1985 Potential for Utilization of Algal Biomass for Components of Diet in CELSS (Controlled Ecological Life Support System).  Society of Automotive Engineers Technical paper series 851388.

• Bouzas, J., Kamarei, A.R., and Karel, M.; 1984 Effect of Extraction procedures on Fluorescent Chromophores in Milk.  J. Food Sci. 50(5) 1515-1516.

• Bouzas, J., Kamarei, A.R., and Karel, M.; 1985 Storage Stability of Milk Fat Globule Membrane.  J. Food Processing and Preservation 9:11-24.

• Kamarei, A.R., and Karel, M.; 1984 Assessment of Autoxidation of Freeze-Dried Meats by a Fluorescent Assay.  J. Food Sci. 49(6) 1517-1520 & 1524.

• Karel, M., and Kamarei, A.R.; 1984 Feasibility of Producing a Range of Food Products from a Limited Range of Undifferentiated Major Food Components.  NASA CR-177329 Ames Research Center, Moffett Fields, California.

• Kamarei, A.R., and Karel, M.; 1983 Effects of Ionizing Radiation on Nitric Oxide Myoglobin.  Part 1:  Effects on the NO-Haem Moiety.  Int. J. Radiation Biol. 44(2) 123-134.

• Kamarei, A.R., and Karel, M.; 1983 Effects of Ionizing Radiation on Nitric Oxide Myoglobin.  Part 2:  Effects on the Globin Moiety.  Int. J. Radiation Biol. 44(2) 135-142.

• Kamarei, A.R., and Karel, M.; 1982 An Improved Method for Preparation of Nitric Oxide Myoglobin.  J. Food Sci. 47:682.

• Kamarei, A.R., Karel, M., and Wierbicki, E.; 1981 Color Stability of Radappertized Cured Meat.  J. Food Sci. 46:37.

• Kamarei, A.R.; 1980 Comments on "Why Nitrite Does Not Impart Color."  Food Tech. 34(10) 36

• Karel, M., Kamarei, A.R., and Wierbicki, E.; 1980 Changes in Meat Pigment as a Result of Radappertization.  Proc. 26th European Meeting of Meat Research Workers, Colorado Springs 1:221.

• Kamarei, A.R., Karel, M., and Wierbicki, E.; 1979 Spectral Studies on the Role of Ionizing Radiation in Color Changes of Radappertized Beef.  J. Food Sci. 44:25.

• Majeed, M, Kamarei, A.R. (2013) Integrated Nutritional Composites Bi-Layer: Joint Health. Sabinsa Corporation, East Windsor, New Jersey – White Paper

PUBLISHED INTERVIEWS & WEBINARS

• Kenward E. (2017) Interview: New Naturex VP Highlights Quality, Authentication and Traceability, FoodIngredientsFirst, 21 Feb. 2017.

• Olivo L. (2013) Weight Management: The Lifestyle Battle, Nutraceutical World, Sept. issue 42-52

• Person T. (2013) Digestion in Depth, Whole Foods, March issue 36-46

• Sepessy C. (2012) Survival of the Strains, Natural Products INSIDER, Sept. 20

• Schofield L (2012) The Weight Loss Market: A Supersized Opportunity, Nutraceuticals World, Sept. 1, 2012

• Sepessy C. (2012) Innovation and Challenges in the Probiotic Market, Natural Products INSIDER, Sept. 21, 2012

• Cantor, S (2012) Delivery Systems: Advances in Tablet and Capsules, Nutritional Outlook, June 2012

• Poveromo, J. (2012) Providing Efficacy in Theory and Practice, Nutrition Industry Executive Magazine, May issue, 28-34

• Peckenpaugh, D. (2012) From Pills to Palates: Expanding Nutritional Opportunities, Food Product Design, May issue

• Cantor, S. (2012) Dose of Appeal, Nutritional Outlook, June issue, 48-52

• Kenny, J. (2012) Delivery Systems: Meeting the Challenges of Change, Nutraceuticals World, July 1 issue, 32-37

• LactoSpore: Probiotic of Choice, Sabinsa Corporation, March 26, 2013

• Innovative Ingredients in Support of Weight Management, Sabinsa Corporation, Nov. 9, 2011